Company: SHPH
Filing Date: 2025-03-13
Form Type: 424B3
Source: 0001493152-25-010109
Chunk: 43

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-13
Form: 424B3
Chunk 43
---
 Securities Underlying Unexercised Options Exercisable 
 (#)                                                      |     | Number                                                     
 of Securities Underlying Unexercised Options Unexercisable 
 (#)                                                        |     | Option         
 Exercise Price 
 ($)            |     | Option          
 Expiration Date |     |                               Stock Awards 
                                     Number 
 of Shares or Units of Stock not yet Vested 
                                       (#)) |     |   |                                  Market 
 Value of Shares or Units not yet Vested 
                                     ($) |
|:----------------|:----|:--------------|:----|:---------------------------------------------------------|:----|:-----------------------------------------------------------|:----|:---------------|:----|:----------------|:----|-------------------------------------------:|:----|:--|----------------------------------------:|
| Mira Jung1      |     | 5/1/23        |     | -                                                        |     | -                                                          |     | -              |     | -               |     |                                      1,194 |     | $ |                                   1,026 |
| Timothy Lorber2 |     | 6/13/24       |     | -                                                        |     | -                                                          |     | -              |     | -               |     |                                     28,455 |     | $ |                                  24,443 |

| (1) | These RSUs vest in                                       
 two installments on the anniversary of the grant date.   |
| (2) | These RSUs vest in                                       
 three installments on the anniversary of the grant date. |

2018 Equity Incentive Plan

Our Plan provides for equity incentives to be granted to our employees, executive officers or directors and to key advisers and consultants. Equity incentives may be in the form of stock options with an exercise price of not less than the fair market value of the underlying shares as determined pursuant to the Plan, restricted stock awards, other stock- based awards, or any combination of the foregoing. The Plan is administered by the Company’s compensation committee or, alternatively, if there is no compensation committee, the Company’s board of directors. We have reserved 3,000,000 shares of our common stock for issuance under the Plan, of which 1,187,189 shares have been granted under the Plan as of the date of this registration statement.

Director Compensation

Each of our non-employee directors, pursuant to the terms of director agreements (the “Director Agreements”), between each of the directors and the Company, receives compensation on an annual basis consisting of $25,000